Ars Pharmaceuticals Inc (SPRY)
SBC to Revenue
36.83%
Quarterly · Period ending:
SPRY SBC to Revenue
Latest reported36.83%period ending
Latest reported36.83%period ending
SPRY Quarterly SBC/Revenue (0.00% → 36.83%)
Latest values, visible window
High-resolution chart · PNG
SPRY sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 36.8263% | |
| 32.7278% | |
| 20.4258% | |
| 17.5041% | |
| 34.1732% | |
| 66.4493% | |
| 4.9237% | |
| 173.646% | |
| 673% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 243.3862% | |
| 0% | |
| 39.819% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |